A Novel Gene Signature Based on CDC20 and FCN3 for Prediction of Prognosis and Immune Features in Patients with Hepatocellular Carcinoma

Figure 2

Functional investigation in accordance with the DEGs between normal and tumor groups in the TCGA group. (a) Barplot graph in terms of KEGG pathways. (b) Bubble graph in terms of GO enrichment using 125 increased genes. (c) Barplot graph in terms of KEGG pathways. (d) Bubble graph in terms of GO enrichment using 155 reduced genes.

(a)

(b)

(c)

(d)